1Nov2018 A Green Light for Business? The Rescheduling of Cannabis-Derived Medicinal Products and the UK’s Anti-Money Laundering Regime 1st November 2018 Daniel Jackson Cannabis investing group, Controlled Drugs Licensing and Proceeds, Daniel Jackson, David Hardstaff, Insights, News & Insights, Regulatory BCL Solicitors, David Hardstaff and Daniel Jackson consider some of the potential implications of the rescheduling of cannabis-derived medicinal products in the UK. Read more